—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Dr. Reddy’s Laboratories Ltd ADR (RDY) — Quality & forensics

As of 2026-10-15 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.

The Closelooknet module scores

48 /100 composite · 7 modules · general weight set

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

2.07 Altman Z-Score

Sits in the grey zone (1.81–2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

4/9 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

-2.57 Beneish M-Score

Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.

Continue: the RDY chart & overview · the earnings record

FAQ · from the current data · as of 2026-10-15

Quick answers

What is Dr. Reddy’s Laboratories Ltd ADR's Closelooknet quality reading?

The composite reads 48/100 across 7 modules, as of 2026-10-15: valuation 62, quality 41, growth 41, balance sheet 58, cash quality 39, capital allocation 48, momentum 45. Closelooknet scores are research diary readings, not ratings or investment advice.

What is Dr. Reddy’s Laboratories Ltd ADR's Altman Z-Score?

2.07, which sits in the grey zone (1.81–2.99) as of 2026-10-15. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is Dr. Reddy’s Laboratories Ltd ADR's Piotroski F-Score?

4 of 9, as of 2026-10-15. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.

What does Dr. Reddy’s Laboratories Ltd ADR's Beneish M-Score indicate?

-2.57 — below the −1.78 manipulation-risk threshold, as of 2026-10-15. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.